KimballJ. T., and KillipT.: Aggressive Treatment of Arrhythmias in Acute Myocardial Infarction: Procedure and Results, Progr. Cardiovasc. Dis.10: 483, 1968.
2.
RotmanM., WagnerG. S., and WallaceA. G.: Bradyarrhythmias in Acute Myocardial Infarction, Circulation45: 703–722 (Mar.) 1972.
3.
GlickG., and YuP. N.: Hemodynamic Changes During Spontaneous Vasovagal Reactions, Am. J. Med.34: 42, 1963.
4.
InnesI. R., NickersonM.: The Pharmacologic Basis of Therapeutics, 4th Ed., edited by GoodmanL. S., and GilmanA., Philadelphia, MacMillan Co., 1970.
5.
EgerI. E.II: Atropine, Scopolamine and Related Compounds, Anesthesiology23: 365, 1962.
6.
ShillingfordJ., and ThomasM.: Treatment of Bradycardia and Hypotension Syndrome with Acute Myocardial Infarction, Am. Heart J.75: 843, 1968.
7.
LownB., FakhroA. M., HoodW. B., and ThornG. W.: The Coronary Care Unit: New Perspectives and Directions, J. Am. Med. Ass.199: 188, 1967.
8.
DeSanctisR. W., BlockP., and HutterA.: Tachyarrhythmias in Myocardial Infarction, Circulation45: 681, 1972.
9.
RowlandM., ThomsonP. D., GuichardA., and MelmonK. L.: Disposition Kinetics of Lidocaine in Normal Subjects, Ann. N.Y. Acad. Sci.
10.
GianellyR., Von der GroebenJ. O., SpivackA. P., and HarrisonD. C.: Effect of Lidocaine on Ventricular Arrhythmias in Patients with Coronary Heart Disease, N.E.J. Med.277: 1215, 1967.
11.
JeresatyR. M., KhanA. H., and LandryA. B.: Sinoatrial Arrest Due to Lidocaine in a Patient Receiving Quinidine, Chest61: 683 (7), 1972.
12.
ThomsonP. D., RowlandM., and MelmonK. L.: The Influence of Heart Failure, Liver Disease, and Renal Failure on the Disposition of Lidocaine in Man, Am. Heart J.82: 417–421(3), 1971.
13.
BeckettA. H., BoyesR. N., and AppletonP. J.: The Metabolism and Excretion of Lidocaine in Man, J. Pharm. Pharmacol.18 (Suppl.) 76, 1966.
14.
MarriottH. J. L., and BiezaC. F.: Alarming Ventricular Acceleration After Lidocaine Administration, Chest61: 682 (7), 1972.
15.
Koch-WeserJ., and KleinS. W.: Procainamide Dosage Schedules. Plasma Concentrations and Clinical Effects, J. Am. Med. Ass.215: 1451. 1971.
16.
WeilyH. S., and GentonE.: Pharmacokinetics of Procainamide. Arch. Inter. Med.130: 366. 1972.
17.
CondemiJ. J., BlomgrewS. E., and VaughanJ. H.: The Procainamide-Induced Lupus Syndrome, Bull. Rheum. Dis.9: 604. 1970
18.
LaddA. T.: Procainamide-Induced Lupus Erythematosus. NEJ. Med.267: 1357, 1962.
19.
JewittD. E., KishonY., ThomasM.: Lidocaine in the Management of Arrhythmias After Acute Myocardial Infarction. Lancet2: 266–268, 1968.
20.
FoldesF. F., MolloyM. B., McNallP. G., and KowkalL. R.: Comparison of Toxicity of Intravenously Given Local Anesthetic Agents in Man, J. Amer. Med. Assoc.172: 1492. 1960.
21.
BinnionP. F., MurtaghG., PollockA. M., and FletcherE.: Relation Between Plasma Lignocaine Levels and Induced Haemodynamic Changes, Brit. Med. J.111: 390, 1969.